Sign Up to like & get
recommendations!
0
Published in 2019 at "Oncotarget"
DOI: 10.18632/oncotarget.26531
Abstract: Although multiple myeloma (MM) has become more treatable in the past decade by application of proteasome inhibitors (PI) and immunomodulatory drugs (IMiDs) [1], there is an urgent need for development of novel treatment alternatives. Monoclonal…
read more here.
Keywords:
combination;
lenalidomide vitamin;
vitamin enhances;
antibody ... See more keywords